This layer contains the location of practitioners authorized to treat opioid dependency with buprenorphine in the latest report year (2022).
This layer contains the location of practitioners authorized to treat opioid dependency with buprenorphine in the latest report year (2023).
Layer displays the locations of substance abuse treatment facilities across the United States. Data are from the Substance Abuse and Mental Health Services Administration (SAMHSA) facility locator, accessed January 2014.
This layer displays the locations of SAMHSA-certified Opioid Treatment Programs. Locations are obtained from the US Substance Abuse and Mental Health Services Administration (SAMHSA) Behavioral Health Treatment Services Locator and are current as of February 8th, 2017.
This layer displays opioid overdose mortality rates from the CDC’s National Vital Statistics System – Mortality database. Data are 5-year aggregates for 2013-17 and grouped by ICD-10 codes.
This layer displays the percentage of Medicare Beneficiaries with a drug or substance use disorder. The prevalence among Medicare beneficiaries is based on Medicare insurance claims (for specific inpatient diagnosis or procedure codes) in 2017.
This layer displays opioid overdose mortality rates from the CDC’s National Vital Statistics System – Multiple Cause of Death database. Data are 5-year aggregates for 2014-18 and grouped by ICD-10 codes.
This layer displays the percentage of Medicare Beneficiaries with a drug or substance use disorder. The prevalence among Medicare beneficiaries is based on Medicare insurance claims (for specific inpatient diagnosis or procedure codes) in 2018.
This layer displays opioid overdose mortality rates from the CDC’s National Vital Statistics System – Multiple Cause of Death database. Data are 5-year aggregates for 2015-19 and grouped by ICD-10 codes.
This layer displays the percentage of Medicare beneficiaries with opioid use disorder in the latest report year (2019).